Freedom-2, Inc. Announces Intellectual Property License Agreement with Brown University.

Freedom-2 Gains the Licensed Patents for the Technology Underlying its Permanent, but Removable Tattoo Ink

NEW YORK -- Freedom-2 Holdings, Inc. (Freedom-2, Inc.'s holding company), pioneers in the development of safe, quality inks for the purpose of permanent but removable tattoos today

Entered on May 15, 2007, the license agreement follows Freedom-2 sponsored research at Brown University in the area microencapsulation of dyes and other compounds. This initial research is the basis for Freedom-2's permanent, but removable tattoo ink.

"The Intellectual Property agreement with Brown University provides Freedom-2 with the ability to continue the research and development partnership with the University during the commercialization of the technology," said Martin Schmeig, CEO of Freedom-2. "The work at Brown, led by Edith Mathiowitz, Ph.D., Professor of Medical Science and Bio Med Molecular Pharmacology, Physiology & Biotechnology, has implications for future applications and we believe this agreement solidifies our current relationship and is the start of a long and productive alliance."

"The agreement between Freedom-2 and Brown University is representative of the collaboration between business and the University that benefit both parties plus the public in known and future unknown ways," said Charles Kingdon, Associate Vice President for Technology Partnerships at Brown University. "Building technology partnerships to serve the broader community is a goal of our program and we are pleased that our on-going work with Freedom-2 will add to consumer safety."

The license agreement grants Freedom-2 a worldwide, nontransferable license to develop, manufacture, and sell products based on the research. A joint US Patent Application number 60/747,141, titled "Particles with High Uniform Loading of Dye and Methods of Preparation Thereof" has been filed and the agreement covers the commercialization of this patented IP. Under the terms of the agreement, Freedom-2 will receive all inventions during the license agreement period that occur as a result of Freedom-2 funding.

The Freedom-2 (F2) ink technology is the first and only patented tattoo ink designed specifically for safe and easy, future removal. F2 uses microscopic bioabsorbable pigments and dyes that are encapsulated in a biocompatible polymer forming a microencapsulated colored bead. These beads are used to make the F2 ink. Tattoo artists use traditional delivery methods to provide an F2 tattoo - the only difference is the ink. An F2 tattoo is easily removed by a single, standard laser treatment that breaks the polymer beads allowing the body to naturally expel the dye trapped inside.

About Freedom-2, Inc.

Founded in 1999, Freedom-2, Inc. is a pioneer in the development of safe, quality inks for the purpose of permanent but removable tattoos and permanent cosmetics. The Freedom-2 ink technology was co-discovered by R. Rox Anderson, M.D., Wellman Center for Photomedicine at the Massachusetts General Hospital, Craig A. Drill, Susanna Mlynarczyk-Evans, Ph.D., UC-San Francisco, Bruce Klitzman, Ph.D. and Kim Edward Koger, M.D., F.A.C.S., of Duke University. Freedom-2, Inc. is a privately held, pre-commercial company with initial funding from private investors, institutional investment firms and private investment vehicles. For more general information about the company log onto www.freedom2ink.com.

About Brown University

The Office of Brown Technology Partnerships is charged with managing the patenting and commercialization of intellectual property generated by members of the Brown Community via partnerships with industry or via the creation of start-up ventures.

Safe Harbor Statement

Some of the statements included in this presentation are forward-looking statements that involve a number of risks and uncertainties, including, but not limited to, statements regarding future market opportunity and future financial performance. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.